Essential website updates between 07:15-07:30am CET 26 April 2024 may cause disruption.

Addis Action Agenda highlights role of IFFIm model

Addis Action Agenda highlights role of IFFIm model

16 July 2015

Ethiopia Conference billed as critical building block in identifying new Sustainable Development Goals calls for wider application of IFFIm funding mechanism

Addis Ababa, Ethiopia, 16 July 2015 – The Financing for Development Conference has called for development organisations to explore the potential for applying Gavi’s International Finance Facility for Immunisation (IFFIm) mechanism to other global issues as well as immunisation.

The Action Agenda, endorsed by representatives of the world’s governments at the four-day Conference (13-16 July) in Addis Ababa, stated: “We encourage consideration of how existing mechanisms, such as IFFIm, might be replicated to address broader development needs. We also encourage exploring additional innovative mechanisms based on models combining public and private resources such as green bonds, vaccine bonds, triangular loans and pull mechanisms, and carbon pricing mechanisms.”

In addition to encouraging the use of innovative financing mechanisms and partnerships to maximise the impact of funding, the Agenda also highlighted other key areas on which to focus development financing and end extreme poverty by 2030. Delegates agreed to work to increase domestic resources and encourage donors to meet their aid commitments.

Critical step

The Addis agreement represents a critical step toward developing of Sustainable Development Goals expected to take over from the Millennium Development Goals in September.

The Agenda also committed governments to “support research and development of vaccines and medicines, as well as preventive measures and treatments for the communicable and non-communicable diseases, in particular those that disproportionately impact developing countries”.

Gavi’s innovative role in achieving this goal was singled-out for recognition. “We will support relevant initiatives, such as Gavi, the Vaccine Alliance, which incentivises innovation while expanding access in developing countries.”

Share this article